Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

To Evaluate Safety and Preliminary Immunogenicity of the Diphtheria-Tetanus-acellular Pertussis Component Combined Vaccine in Children Aged 2 Months to 6 Years: A Randomized, Blinded, Active-controlled Phase I Clinical Trial

NCT06184542 is registered in ClinicalTrials.gov with Institute of Medical Biology, Chinese Academy of Medical Sciences as lead sponsor.

NCT NCT06184542
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06184542 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
To Evaluate Safety and Preliminary Immunogenicity of the Diphtheria-Tetanus-acellular Pertussis Component Combined Vaccine in Children Aged 2 Months to 6 Years: A Randomized, Blinded, Active-controlled Phase I Clinical Trial
Lead sponsor
Institute of Medical Biology, Chinese Academy of Medical Sciences
Phase
Phase 1
Overall status
Recruiting
Start date
December 23, 2023
Completion date
November 1, 2026
Enrollment
460 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

diphtheria, pertussis, tetanus